GiaMedica

In Vitro Fertilization and Tube Baby Treatment in Turkey

2026-07-29 00:00:00.000Z

In Vitro Fertilization (IVF), an assisted reproduction method in which an embryo obtained by bringing egg and sperm together in a laboratory environment is placed in the uterus. It is the most effective treatment option for couples unable to have children, and Turkey is among the world's leading countries in this field with its experienced centers, modern embryology laboratories, and accessible costs.

Quick Overview

  • One treatment cycle: Approximately 4-6 weeks
  • Egg retrieval: 15-20 minutes under light anesthesia
  • Embryo transfer: Without anesthesia, a few minutes
  • Result test: Blood test 10-12 days after transfer
  • Main factor determining success: Woman's age
  • International patients: 18-21 days in a single stay or two separate trips

What is IVF Treatment?

In medical terms, called in vitro fertilization (IVF), test tube baby is based on achieving fertilization under laboratory conditions that cannot occur naturally. The ovaries are stimulated with medication to develop multiple eggs, the matured eggs are retrieved, fertilized with sperm, and the developing embryo is placed in the uterus.

A couple's failure to achieve pregnancy within one year despite regular unprotected intercourse is defined as infertility. If the woman is over 35 years old, this period is reduced to six months. However, IVF is not always a first-line treatment; depending on the source of the problem, simpler treatments may take priority.

Causes of Infertility

SourceMain Causes
Female-relatedOvulation disorders (PCOS), blocked tubes, endometriosis, diminished ovarian reserve, intrauterine adhesions, and fibroids
Male-relatedAbnormalities in sperm count, motility, or morphology, varicocele, absence of sperm (azoospermia), hormonal and genetic causes
Both partnersContributing factors from both sides exist in a significant portion of cases
UnexplainedFailure to achieve pregnancy despite all tests being normal

Evaluation should always be done as a couple. A process examining only the woman often leads to wasting time in a significant portion of cases.

Treatment Stages

Assisted reproduction treatments are planned gradually according to the nature of the problem. Proceeding directly to IVF is not always correct; however, in some cases (blocked tubes, advanced male factor, advanced age), skipping stages is necessary.

1. Ovulation Treatment (Ovulation Induction)

In women with ovulation problems, egg development is supported with medication in pill or injection form, monitored by ultrasound, and intercourse timing is planned. It is the simplest and most economical stage. Usually 3-6 cycles are attempted.

2. Insemination (Intrauterine Insemination - IUI)

Sperm prepared and concentrated in the laboratory is placed directly into the uterus through a fine catheter. The procedure is painless and takes a few minutes. At least one open tube is required. It is suitable for mild-to-moderate male factor and unexplained infertility. Usually after 3-4 attempts without success, IVF is pursued.

3. IVF (IVF / ICSI)

Applied when other methods have failed or are initially unsuitable. Blocked tubes, severe male factor, advanced age, diminished ovarian reserve, and advanced-stage endometriosis are direct IVF indications.

IVF Methods and Laboratory Techniques

Classical IVF and Microinjection (ICSI)

In classical IVF, the egg and sperm are placed in the same dish and fertilization is expected to occur spontaneously. In the ICSI (microinjection) method, a single sperm is injected directly into the egg using a special needle under a microscope. It is preferred in cases where male factor is present and when fertilization problems occurred in previous cycles; today, the vast majority of procedures are performed with ICSI.

IMSI and PICSI

IMSI is the selection of sperm by examining it at very high magnification. PICSI is a selection method that evaluates sperm maturity. These come into consideration in selected cases with repeated failures and high sperm DNA damage; routine use in all patients is not recommended.

TESE and Micro-TESE

In men with no sperm in the ejaculate (azoospermia), sperm is obtained surgically from testicular tissue. Micro-TESE is the microscopically-guided selection and retrieval of tubules with sperm production, offering higher sperm recovery rates with less tissue damage. Obtained sperm is used with ICSI or frozen and stored.

Blastocyst Transfer

Embryos are monitored in the laboratory until day 5. Embryos reaching this stage have higher developmental potential, increasing selection chances. If embryo numbers are limited, day 3 transfer may be preferred.

Embryo and Egg Freezing (Vitrification)

Quality embryos remaining after transfer are preserved using rapid freezing methods. This allows frozen embryo transfer (FET) in subsequent attempts without repeating ovarian stimulation and egg retrieval. This reduces both cost and physical burden. Egg freezing can be applied within medical indications.

Preimplantation Genetic Testing (PGT)

Genetic examination of a few cells retrieved from the embryo before transfer. PGT-A evaluates chromosome number, while PGT-M evaluates single gene diseases known in the family. It comes into consideration with advanced maternal age, recurrent miscarriage, repeated failed transfers, and hereditary disease carrier status. Routine application in all patients is not recommended.

Time-Lapse (Continuous Imaging) Systems

Allows continuous monitoring of embryos without removing them from the incubator. Reduces environmental fluctuations and assists in embryo selection.

Note Regarding Additional Procedures

Evidence that additional procedures such as endometrial receptivity testing, assisted hatching, embryo glue, endometrial scratching, and various immune treatments increase live birth rates is limited and controversial. These procedures increase costs. You have the right to ask for every recommended additional procedure: "what data supports this for my specific situation?"

Pre-Treatment Tests

  1. Ovarian reserve: AMH blood test and antral follicle count by ultrasound
  2. Hormone profile: FSH, LH, estradiol, TSH, prolactin
  3. Uterus and tube assessment: Ultrasound, if necessary hysterosalpingography (HSG) or hysteroscopy
  4. Sperm analysis: Repeated if necessary; DNA fragmentation testing in advanced cases
  5. Infection screening: Hepatitis B-C, HIV, syphilis for both partners
  6. Genetic evaluation: Karyotype analysis if recurrent miscarriage, azoospermia, or family history is present

Treatment Process Step by Step

StageWhat is Done?Duration
1. PreparationTests, protocol selection, preparatory treatment if needed2-4 weeks
2. Ovarian stimulationDaily injections, 2-3 ultrasounds and blood tests for monitoring8-12 days
3. Trigger injectionFinal maturation of eggs is achieved34-36 hours before retrieval
4. Egg retrievalUnder light anesthesia with ultrasound guidance15-20 minutes
5. FertilizationICSI or classical IVF is applied the same daySame day
6. Embryo monitoringDevelopment is monitored, transfer day is determined3-5 days
7. Embryo transferPlacement into uterus through fine catheter, anesthesia not requiredA few minutes
8. Support therapyProgesterone support is usedUntil test day
9. Pregnancy testBeta hCG measurement in blood10-12 days after transfer

In patients using the long protocol, the process may be extended by approximately two weeks due to the suppression phase before stimulation. A complete cycle averages 4-6 weeks.

Success Rates

The strongest factor determining success in IVF is the woman's age. As age advances, egg numbers decrease and chromosomal error rates increase; this directly reduces the chance of the embryo converting to a healthy pregnancy.

Woman's AgeLive Birth Per Transfer (approximately)
Under 35 years35-45%
35-3730-35%
38-4018-25%
41-428-15%
43 years and olderBelow 5%

How Should Success Rate Numbers Be Interpreted?

  • Which measure? "Pregnancy rate" and "live birth rate" are different things. The truly meaningful measure is live birth rate.
  • Per what? Whether calculated per cycle started or per transfer significantly changes the outcome.
  • Which patient group? A center accepting only young and good-prognosis patients naturally reports higher rates.
  • Cumulative chance: Even if a single cycle's rate seems low, the total chance increases significantly after three cycles including frozen embryo transfers.

Other Factors Affecting Success

Risks and Side Effects

Legal Framework in Turkey

In Turkey, assisted reproduction practices are comprehensively regulated by the Ministry of Health's ART Regulation. Centers are licensed and regularly inspected. It is mandatory to know these rules before planning treatment.

What International Patients Must Know

  • Egg, sperm, and embryo donation are prohibited in Turkey. Treatment can only be performed with the couple's own reproductive cells.
  • Surrogacy is prohibited.
  • Treatment is legally applied only to married couples; marriage certificate and ID are requested at application.
  • Sex selection is prohibited; it can only be done for medical indications to prevent serious hereditary diseases related to sex.
  • Patients seeking donor treatment cannot receive this treatment in Turkey. People in this situation should plan considering the regulations of their own country as well.

Embryo Transfer Number Limit

SituationEmbryos that Can Be Transferred
Under 35 years, 1st and 2nd attemptsSingle embryo
Under 35 years, 3rd and subsequent attemptsMaximum two embryos
35 years and over, all attemptsMaximum two embryos

This limit has been established to prevent multiple pregnancies that carry serious risks for mother and baby. Single embryo transfer, combined with the use of frozen embryos in subsequent cycles, reduces risk without lowering cumulative success.

Why Turkey?

High Case Volume and Experience

Turkey has many licensed IVF centers and teams performing high numbers of procedures annually. One of the most important factors determining the outcome in the embryology laboratory is the embryologist's annual procedure volume and experience.

Strict Licensing and Oversight

Centers are licensed by the Ministry of Health, and laboratory standards and personnel qualifications are regularly inspected. This creates a predictable quality baseline for patients.

Cost Advantage

Treatment costs are significantly lower compared to Western Europe and North America. This difference stems not from laboratory technology or drug quality, but from operating costs and exchange rates. The same international medications and supplies are used.

No Waiting Time

In many countries, waiting lists for IVF through public systems can extend for months. Time directly affects success in IVF; advancing age reduces chances. In Turkey, treatment can typically be initiated within weeks.

Current Laboratory Infrastructure

Remote Pre-Assessment and Coordination

Before traveling, patients can share test results to receive pre-assessment, protocol planning, and schedule. A portion of the stimulation treatment can be continued in the patient's home country with remote monitoring. This significantly shortens the total stay.

Transportation and Accommodation

Proximity to Europe, the Middle East, and Central Asia, extensive flight networks, and accommodation-transfer arrangements for medical tourism facilitate the process. Since the partner should be present on the day of egg retrieval, couple-centered program planning is common.

Calendar for International Patients

ModelHow It Works?Stay
Single tripEntire process from stimulation to transfer in Turkey18-21 days
© GiaMedica · www.giamedica.com